I am very pleased with the shake up at HRT. I feel it was done in the best interest of the shareholders. HRT is not a stock to sell but one to buy, especially now at current levels. The fact that O'Brian will no long be a Director I feel will have no effect on the deal between Rosneft and HRT.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.